CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities
Net income	$ 1,247	$ 6,529
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation expense	2,022	2,075
Amortization of intangible assets	3,009	3,797
Deferred tax expense (benefit) from stock issuances	172	(152)
Amortization of deferred financing costs	460	600
Stock-based compensation	7,150	7,230
Changes in fair value of contingent consideration		362
Provisions for accounts receivable	738	501
Deferred tax provision	68	(245)
Loss on disposal of fixed assets	4	32
Changes in operating assets and liabilities:
Accounts receivable and contract assets	(8,090)	(5,778)
Prepaid expense and other assets	1,008	(26)
Accounts payable	189	509
Contract liabilities	(2,184)	(1,865)
Accrued expenses	9	(2,415)
Net cash provided by operating activities	5,802	11,154
Cash flows from investing activities
Purchase of furniture, fixtures and equipment	(1,115)	(3,603)
Net cash used in investing activities	(1,115)	(3,603)
Cash flows from financing activities
Proceeds from debt	5,000
Principal payments on borrowings	(7,688)	(8,574)
Payment of the Alsbridge Notes		(7,000)
Proceeds from issuance of employee stock purchase plan shares	575	642
Payment of contingent consideration	(865)	(1,200)
Payments related to tax withholding for stock-based compensation	(2,732)	(2,743)
Equity securities repurchased	(2,976)	(2,879)
Net cash used in financing activities	(8,686)	(21,754)
Effect of exchange rate changes on cash	(433)	(710)
Net decrease in cash, cash equivalents, and restricted cash	(4,432)	(14,913)
Cash, cash equivalents, and restricted cash, beginning of period	18,725	28,514
Cash, cash equivalents, and restricted cash, end of period	14,293	13,601
Non-cash investing and financing activities:
Issuance of treasury stock for vested restricted stock awards	$ 847	$ 5,151